According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase of stable a ...
Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
(MENAFN- EIN Presswire) EINPresswire/ -- "The synthetic small molecule active pharmaceutical ingredients (APIs) market is characterized by the presence of established pharmaceutical manufacturers, ...
According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase of stable and sustained ...